Hard to Treat Diseases (Pink Sheets: HTDS) will proceed with the Share Buyback Program following the news on April 1, 2010 in an effort to raise the value of the company’s shares.
Xplosive Stocks, an online financial publication, provides investors timely stock market information.
Sign Up Today for our Free Stock Newsletter
HTDS management plans to continue with the program, using financing from sales of some of their disposable assets. HTDS management is under the opinion that this financing should be enough to raise the price of the security to the true value of HTDS.
HTDS is a holdco of a China based Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Mellow Hope is the biggest exporter of Biological Vaccines in China. Based on the cooperation with Institutes of Medical Biology and Pharmaceutical manufacturers, Mellow Hope provides a wide range of vaccines with high quality, safety and efficacy.
Sign up for the free Xplosive Stocks newsletter. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by Xplosive Stocks can sign up for free by visiting our website.
About Us
Xplosive Stock is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We focus on Xplosive Stocks and track small cap companies that are on the brink of a financial breakout. To feature a company on our website please contact us at the email listed below.
Please click here to read the full disclaimer.
